UroGen Reports Five-Year JELMYTO Follow-Up in LG-UTUC

Final Olympus follow-up showed a median duration of response of 47.8 months in LG-UTUC complete responders. Among 20 patients with extended follow-up, median duration of response was not estimable; 75% were event-free and none had progressed to high-grade disease as of March 2025.